Expert insights. Personalized for you.
Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here. MORE
DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans. MORE
DarioHealth Corp. MORE
Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching. MORE
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) MORE
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S. MORE
The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform. MORE
DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. MORE
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp. MORE
MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ). MORE
Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. MORE
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. MORE
NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp. MORE
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. MORE
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. MORE
NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp. MORE
BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here. MORE
BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19. Read more here. MORE
The post [DarioHealth in PR Newswire] DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019 appeared first on OurCrowd. DarioHealth Corp. MORE
digital therapeutics Related Topics OurCrowd
JUNE 18, 2020
Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m.
OurCrowd
SEPTEMBER 23, 2019
The post [DarioHealth in PR Newswire] DarioHealth CEO Erez Raphael Presents to Digital Therapeutics Leaders at DTx East 2019 appeared first on OurCrowd. DarioHealth Corp.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
OurCrowd
MAY 13, 2020
BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services. Read more here.
OurCrowd
JUNE 14, 2020
Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.
OurCrowd
DECEMBER 3, 2019
Global digital therapeutics innovation leader, DarioHealth Corp. NASDAQ: DRIO) announced today the launch of the Dario-powered digital diabetes program on Walmart.com. Read more here.
|
OurCrowd
MAY 6, 2020
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S.
OurCrowd
MAY 4, 2020
NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.
OurCrowd
MAY 6, 2020
Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.
OurCrowd
FEBRUARY 24, 2020
NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.
Angel Capital Association
MAY 18, 2020
MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ).
|
OurCrowd
DECEMBER 22, 2019
The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform.
OurCrowd
APRIL 5, 2020
BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19. Read more here.
OurCrowd
NOVEMBER 15, 2019
Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.
OurCrowd
NOVEMBER 15, 2019
DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans.
OurCrowd
JULY 30, 2019
DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels.
OurCrowd
JULY 30, 2019
DarioHealth Corp.
OurCrowd
OCTOBER 24, 2019
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S.
OurCrowd
AUGUST 15, 2019
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”)
OurCrowd
SEPTEMBER 18, 2019
DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.
39 
Let's personalize your content